A research team in Asia has developed a method for tracking, or ‘tracing’, cells that overcomes the limitations of existing methods. The team’s fluorescent organic tracers will provide researchers with a noninvasive tool to continually track biological processes for long periods. Applications for the tracers include following carcinogenesis or the progress of interventions such as stem cell therapies.
Bin Liu and Ben Zhong Tang of the A*STAR Institute of Materials Research and Engineering in Singapore and their co-workers developed probes composed of a small number of molecules that aggregate. The aggregation means that the probes have more detectable fluorescence and less leakage than that provided by single-molecule probes. Importantly, rather than ‘blink’, the team’s tracers show steady fluorescence, and do not contain heavy metal ions that can be toxic for living systems.
Compared with their existing inorganic counterparts, the team’s carbon-based tracers show greater chemical stability and improved biocompatibility with cell biochemistry. They are also more resistant to bleaching by light and do not interfere with normal biochemical processes. Furthermore, the fluorescent signals emitted by the probes do not overlap with the signal naturally emitted by cells.
The tracers developed by Liu, Tang and their colleagues are examples of ‘quantum dots’, as they are composed of a small number of molecules with optical characteristics that rely on quantum-mechanical effects. Technically, they are referred to as aggregation-induced emission dots (AIE dots) as they become photostable and highly efficient fluorescent emitters when their component molecules aggregate.
The assembly of the AIE dots began with the synthesis of organic molecules, specifically 2,3-bis(4-
(phenyl(4-(1,2,2-triphenylvinyl)phenyl)amino)phenyl)fumaronitrile (TPETPAFN), which the researchers then encapsulated in an insoluble lipid-based matrix. Next, the researchers attached small peptide molecules derived from the human immunodeficiency virus (HIV) to exploit the ability of these peptides to promote efficient uptake of AIE dots into living cells.
“Our AIE dots could track isolated human breast cancer cells in vitro for 10 to 12 generations and glioma tumor cells in vivo in mice for 21 days,” says Liu. “They outperform existing commercial inorganic quantum dots, and open a new avenue in the development of advanced fluorescent probes for following biological processes such as carcinogenesis, stem cell transplantation and other cell-based therapies.”
Future work by Liu, Tang and co-workers will aim to broaden the application of the organic tracers for their use in conjunction with magnetic resonance and nuclear imaging techniques.
The A*STAR‐affiliated researchers contributing to this research are from the Institute of Materials Research and Engineering.